AMENDMENT NO. 3 TO NOTE EXCHANGE AND PURCHASE AGREEMENTNote Exchange and Purchase Agreement • February 28th, 2013 • VistaGen Therapeutics, Inc. • Pharmaceutical preparations • New York
This Amendment to Note Exchange and Purchase Agreement (“Amendment No. 3”) is entered into as of February 22, 2013 by and between VistaGen Therapeutics, Inc., a Nevada corporation (the “Company”) and Platinum Long Term Growth VII, LLC, a Delaware limited liability company (“Platinum”). Unless otherwise specified herein, all capitalized terms set forth in this Amendment shall have the meanings as set forth in the Agreement.
